• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    4.38 Up 0.02(0.46%) Dec 19, 4:00PM EST
    Add to Portfolio
    Prev Close:4.36
    Open:4.36
    Bid:N/A
    Ask:12.50 x 600
    1y Target Est:18.00
    Beta:1.935
    Earnings Date:Feb 18 - Feb 25 (Est.)
    Day's Range:4.14 - 4.41
    52wk Range:3.12 - 25.44
    Volume:178,893
    Avg Vol (3m):531,791
    Market Cap:59.99M
    P/E (ttm):N/A
    EPS (ttm):-2.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADHD

    Comparison

    Symbol% ChgMkt Cap
    ADHDUp 0.46%59.99M
    JNJDown 1.18%295.45B
    NVSUp 0.04%228.83B
    SHPGDown 1.88%42.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.55
    Quarterly EPS Est (Dec-14) :-0.64
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback